SCHEMBL29043266

SCHEMBL29043266

Cc1ccc(S(=O)(=O)O)c(C(C)CO[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.31

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 2/20 0.31
▸ APLNR P35414 2/20 0.31
▸ MEP1B Q16820 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ ALPL P05186 2/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ GAA P10253 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ ATM Q13315 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30461153 1.00 NR3C1 (0.31) NR3C1APLNRMEP1BALDH1A1CYP2C19
SCHEMBL25171404 0.88 DUT (0.30) APLNRMEP1BALDH1A1CYP2C19LMNA
SCHEMBL28977729 0.88 DUT (0.30) APLNRMEP1BALDH1A1CYP2C19LMNA
SCHEMBL20583291 0.83 POLB (0.32) NR3C1MEP1BALDH1A1CYP2C19ALPL
SCHEMBL20294715 0.80 DUT (0.33) —
SCHEMBL15988245 0.77 ALDH1A1 (0.40) MEP1BALDH1A1CYP2C19LMNAMEN1
SCHEMBL29020955 0.77 PLA2G2C (0.38) —
SCHEMBL9615904 0.76 RORC (0.39) NR3C1MEP1BALDH1A1CYP2C19LMNA
SCHEMBL9724989 0.76 RORC (0.39) NR3C1MEP1BALDH1A1CYP2C19LMNA
SCHEMBL20583465 0.75 ATM (0.36) NR3C1MEP1BALDH1A1CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111902417-B Diaryl macrocyclic compound, pharmaceutical composition and application thereof 北京普祺医药科技股份有限公司 2023-07-28 — — CN disclosed
CN-111902417-A Diaryl macrocycle compound, pharmaceutical composition and application thereof 北京普祺医药科技有限公司 2020-11-06 — — CN disclosed
Send feedback